Total planned funding: $259,249,858
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Namibia | $259,249,858 |
Organizational Types
| NGO | $78,698,831 |
| Private Contractor | $62,744,680 |
| Host Country Government Agency | $47,098,452 |
| Own Agency | $23,262,582 |
| University | $20,053,108 |
| Unknown | $11,877,341 |
| Other USG Agency | $6,545,839 |
| Parastatal | $5,477,938 |
| Multi-lateral Agency | $2,150,000 |
| FBO | $707,328 |
| Implementing Agency | $633,759 |
Program Areas
| Treatment | $67,373,519 |
| Care | $55,676,513 |
| Prevention | $51,981,728 |
| Governance and Systems | $45,346,891 |
| Testing | $22,721,351 |
| Management and Operations | $16,149,856 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $51,606,068 |
| HVCT: Testing: HIV Testing and Counseling | $22,721,351 |
| HBHC: Care: Adult Care and Support | $21,580,057 |
| HKID: Care: Orphans and Vulnerable Children | $21,530,443 |
| OHSS: Health Systems Strengthening | $21,141,076 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $19,106,585 |
| HVSI: Strategic Information | $17,953,050 |
| HVMS: Management and Operations | $16,149,856 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $14,837,269 |
| HTXD: Treatment: ARV Drugs | $13,927,468 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $12,518,815 |
| HVTB: Care: TB/HIV | $10,069,017 |
| HLAB: Laboratory Infrastructure | $6,252,765 |
| HMBL: Biomedical Prevention: Blood Safety | $3,895,000 |
| PDCS: Care: Pediatric Care and Support | $2,496,996 |
| PDTX: Treatment: Pediatric Treatment | $1,839,983 |
| HMIN: Biomedical Prevention: Injection Safety | $1,607,456 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $16,603 |
Top Partner Programs
Potentia Namibia:
$25,530,029
Countries/Regions
University of Washington:
$18,856,897
Countries/Regions
Pact, Inc.:
$18,684,881
Countries/Regions